$688 Million is the total value of TANG CAPITAL MANAGEMENT LLC's 89 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 44.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANAB | ANAPTYSBIO INC | $81,462,731 | +21.5% | 2,628,678 | 0.0% | 11.84% | +43.9% | |
| ALT | Buy | ALTIMMUNE INC | $44,422,403 | +33.8% | 2,700,450 | +3.8% | 6.45% | +58.5% |
| BLUE | Sell | BLUEBIRD BIO INC | $32,077,854 | -20.0% | 4,635,528 | -26.8% | 4.66% | -5.2% |
| TARS | Sell | TARSUS PHARMACEUTICALS INC | $29,343,236 | -18.0% | 2,001,585 | -4.2% | 4.26% | -2.8% |
| BCAB | Buy | BIOATLA INC | $25,773,627 | +70.2% | 3,124,076 | +58.8% | 3.74% | +101.6% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $24,953,250 | +24.7% | 105,000 | +5.0% | 3.62% | +47.7% |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $24,681,600 | +690.3% | 320,000 | +357.1% | 3.59% | +836.3% |
| IMCR | IMMUNOCORE HLDGS PLCads | $23,147,592 | +21.6% | 405,600 | 0.0% | 3.36% | +44.0% | |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $21,840,000 | +131.0% | 1,120,000 | +148.9% | 3.17% | +173.5% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $21,607,975 | -17.3% | 3,196,446 | +77.6% | 3.14% | -2.0% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $20,240,339 | +11.8% | 692,925 | -21.5% | 2.94% | +32.4% |
| BGNE | Sell | BEIGENE LTDsponsored adr | $18,694,900 | +32.1% | 85,000 | -19.0% | 2.72% | +56.5% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $16,646,000 | +10.1% | 1,450,000 | +20.8% | 2.42% | +30.4% |
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $15,494,120 | +12.8% | 281,200 | -9.3% | 2.25% | +33.7% |
| PCVX | New | VAXCYTE INC | $14,385,000 | – | 300,000 | +100.0% | 2.09% | – |
| MRNA | New | MODERNA INC | $14,369,600 | – | 80,000 | +100.0% | 2.09% | – |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $12,700,800 | -57.3% | 240,000 | -62.5% | 1.84% | -49.5% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $11,526,000 | +40.1% | 170,000 | +13.3% | 1.68% | +66.0% |
| NKTX | Buy | NKARTA INC | $11,201,300 | +28.4% | 1,870,000 | +182.1% | 1.63% | +52.1% |
| HRTX | Sell | HERON THERAPEUTICS INC | $9,389,835 | -67.5% | 3,755,934 | -45.1% | 1.36% | -61.5% |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $9,304,000 | +30.3% | 200,000 | +45.2% | 1.35% | +54.3% |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $8,988,000 | +16.7% | 600,000 | 0.0% | 1.31% | +38.2% | |
| ALBO | Sell | ALBIREO PHARMA INC | $8,902,628 | -58.2% | 411,968 | -62.5% | 1.29% | -50.5% |
| BIO | Sell | BIO RAD LABS INCcl a | $8,830,290 | -66.9% | 21,000 | -67.2% | 1.28% | -60.8% |
| CGEM | Buy | CULLINAN ONCOLOGY INC | $8,537,387 | +6.7% | 809,231 | +29.7% | 1.24% | +26.4% |
| IONS | IONIS PHARMACEUTICALS INC | $7,554,000 | -14.6% | 200,000 | 0.0% | 1.10% | +1.1% | |
| LLY | New | LILLY ELI & CO | $7,316,800 | – | 20,000 | +100.0% | 1.06% | – |
| New | THIRD HARMONIC BIO INC | $7,310,000 | – | 1,700,000 | +100.0% | 1.06% | – | |
| CNCE | Buy | CONCERT PHARMACEUTICALS INC | $6,716,000 | -0.1% | 1,150,000 | +14.7% | 0.98% | +18.4% |
| IMGN | Sell | IMMUNOGEN INC | $6,323,271 | -11.8% | 1,274,853 | -15.0% | 0.92% | +4.6% |
| EOLS | Buy | EVOLUS INC | $6,079,255 | +1967.8% | 809,488 | +2116.9% | 0.88% | +2352.8% |
| CTMX | Buy | CYTOMX THERAPEUTICS INC | $5,616,712 | +10.7% | 3,510,445 | +0.3% | 0.82% | +31.2% |
| ACET | New | ADICET BIO INC | $5,364,000 | – | 600,000 | +100.0% | 0.78% | – |
| GNFT | GENFIT S Aads | $5,255,924 | +20.2% | 1,197,522 | 0.0% | 0.76% | +42.5% | |
| GLPG | Sell | GALAPAGOS NVspon adr | $5,101,481 | -46.8% | 114,950 | -48.9% | 0.74% | -37.0% |
| CYTK | New | CYTOKINETICS INC | $5,040,200 | – | 110,000 | +100.0% | 0.73% | – |
| Buy | PYXIS ONCOLOGY INC | $4,650,738 | +67.2% | 3,470,700 | +145.9% | 0.68% | +98.2% | |
| BNTX | BIONTECH SEsponsored ads | $4,506,600 | +11.4% | 30,000 | 0.0% | 0.66% | +32.1% | |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $4,407,672 | -35.4% | 36,090 | -45.4% | 0.64% | -23.5% |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $4,404,500 | +10.1% | 50,000 | 0.0% | 0.64% | +30.3% | |
| ITOS | Sell | ITEOS THERAPEUTICS INC | $4,232,151 | -76.3% | 216,700 | -76.9% | 0.62% | -71.9% |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $3,917,150 | +0.8% | 392,500 | 0.0% | 0.57% | +19.3% | |
| ALLK | Sell | ALLAKOS INC | $3,771,882 | -53.4% | 447,967 | -66.2% | 0.55% | -44.8% |
| BEAM | Buy | BEAM THERAPEUTICS INC | $3,715,450 | +56.0% | 95,000 | +90.0% | 0.54% | +84.9% |
| New | AMYLYX PHARMACEUTICALS INC | $3,695,000 | – | 100,000 | +100.0% | 0.54% | – | |
| GRPH | GRAPHITE BIO INC | $3,652,000 | +4.7% | 1,100,000 | 0.0% | 0.53% | +24.1% | |
| SBTX | ARS PHARMACEUTICALS INC | $3,492,719 | +61.6% | 409,463 | 0.0% | 0.51% | +91.3% | |
| EGRX | EAGLE PHARMACEUTICALS INC | $3,474,190 | +10.6% | 118,857 | 0.0% | 0.50% | +31.2% | |
| INSM | Sell | INSMED INC | $3,320,736 | -69.2% | 166,203 | -66.8% | 0.48% | -63.5% |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $3,192,000 | +205.7% | 300,000 | +200.0% | 0.46% | +262.5% |
| New | ZYMEWORKS DEL INC | $3,144,000 | – | 400,000 | +100.0% | 0.46% | – | |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $3,058,986 | -41.5% | 147,920 | -26.0% | 0.44% | -30.8% |
| LEGN | Sell | LEGEND BIOTECH CORPsponsored ads | $2,995,200 | -8.2% | 60,000 | -25.0% | 0.44% | +8.8% |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $2,735,660 | -59.4% | 2,738,947 | -26.8% | 0.40% | -51.9% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $2,718,600 | +94.6% | 60,000 | +200.0% | 0.40% | +131.0% |
| ALGS | Buy | ALIGOS THERAPEUTICS INC | $2,683,739 | +45.7% | 2,816,391 | +68.2% | 0.39% | +72.6% |
| Sell | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $2,579,997 | +28.4% | 245,714 | -5.1% | 0.38% | +52.4% | |
| Sell | 2SEVENTY BIO INC | $2,342,500 | -46.3% | 250,000 | -16.7% | 0.34% | -36.4% | |
| New | BIOHAVEN LTD | $1,943,200 | – | 140,000 | +100.0% | 0.28% | – | |
| ASLN | Sell | ASLAN PHARMACEUTICALS LTDads | $1,931,373 | -43.0% | 5,364,925 | -5.1% | 0.28% | -32.3% |
| MTCR | Buy | METACRINE INC | $1,903,575 | +128.5% | 4,250,000 | +147.3% | 0.28% | +171.6% |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $1,895,159 | -49.3% | 272,293 | -61.1% | 0.28% | -40.0% |
| CTIC | CTI BIOPHARMA CORP | $1,803,000 | +3.3% | 300,000 | 0.0% | 0.26% | +22.4% | |
| BPMC | BLUEPRINT MEDICINES CORP | $1,752,400 | -33.5% | 40,000 | 0.0% | 0.26% | -21.1% | |
| New | TONIX PHARMACEUTICALS HLDG C | $1,754,263 | – | 4,500,419 | +100.0% | 0.26% | – | |
| ATHA | New | ATHIRA PHARMA INC | $1,538,192 | – | 485,234 | +100.0% | 0.22% | – |
| ARVN | Buy | ARVINAS INC | $1,026,300 | +15.3% | 30,000 | +50.0% | 0.15% | +36.7% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $944,527 | -79.0% | 21,192 | -86.8% | 0.14% | -75.2% |
| CHRS | Sell | COHERUS BIOSCIENCES INC | $917,928 | -87.3% | 115,900 | -84.5% | 0.13% | -85.0% |
| AUPH | AURINIA PHARMACEUTICALS INC | $864,000 | -42.6% | 200,000 | 0.0% | 0.13% | -31.5% | |
| SIOX | New | SIO GENE THERAPIES INC | $870,000 | – | 2,000,000 | +100.0% | 0.13% | – |
| Sell | TSCAN THERAPEUTICS INC | $797,715 | -53.1% | 514,655 | -7.8% | 0.12% | -44.5% | |
| OLMA | OLEMA PHARMACEUTICALS INC | $781,369 | -11.2% | 318,926 | 0.0% | 0.11% | +5.6% | |
| ORTX | ORCHARD THERAPEUTICS PLCspon ads | $742,000 | -25.8% | 2,000,000 | 0.0% | 0.11% | -12.2% | |
| BOLT | Buy | BOLT BIOTHERAPEUTICS INC | $520,000 | +75.7% | 400,000 | +100.0% | 0.08% | +111.1% |
| ELEV | New | ELEVATION ONCOLOGY INC | $455,861 | – | 479,854 | +100.0% | 0.07% | – |
| New | ACELRX PHARMACEUTICALS INC | $440,700 | – | 195,000 | +100.0% | 0.06% | – | |
| CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $406,500 | -87.6% | 10,000 | -80.0% | 0.06% | -85.3% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $371,069 | -73.0% | 164,190 | -61.8% | 0.05% | -68.0% |
| SURF | New | SURFACE ONCOLOGY INC | $352,311 | – | 429,647 | +100.0% | 0.05% | – |
| RLMD | Sell | RELMADA THERAPEUTICS INC | $349,000 | -97.6% | 100,000 | -75.0% | 0.05% | -97.2% |
| LIFE | Sell | ATYR PHARMA INC | $270,312 | -91.9% | 123,430 | -88.9% | 0.04% | -90.5% |
| GOSS | Sell | GOSSAMER BIO INC | $217,000 | -92.8% | 100,000 | -60.0% | 0.03% | -91.3% |
| MOLN | Buy | MOLECULAR PARTNERS AGads | $144,100 | +37.2% | 22,000 | +40.3% | 0.02% | +61.5% |
| RVPH | New | REVIVA PHARMACEUTCLS HLDGS I | $102,531 | – | 24,125 | +100.0% | 0.02% | – |
| VINC | Sell | VINCERX PHARMA INC | $103,797 | -92.7% | 101,762 | -90.1% | 0.02% | -91.4% |
| New | LIANBIOsponsored ads | $97,744 | – | 59,600 | +100.0% | 0.01% | – | |
| RPHM | New | RENEO PHARMACEUTICALS INC | $71,268 | – | 30,587 | +100.0% | 0.01% | – |
| Sell | PARDES BIOSCIENCES INC | $57,034 | -93.8% | 33,748 | -93.3% | 0.01% | -92.9% | |
| ACRX | Exit | ACELRX PHARMACEUTICALS INC | $0 | – | -388,468 | -100.0% | -0.01% | – |
| Exit | INSPIRATO INCORPORATED*w exp 02/11/2027 | $0 | – | -365,000 | -100.0% | -0.01% | – | |
| FIXX | Exit | HOMOLOGY MEDICINES INC | $0 | – | -214,898 | -100.0% | -0.04% | – |
| ALEC | Exit | ALECTOR INC | $0 | – | -100,000 | -100.0% | -0.12% | – |
| LPTX | Exit | LEAP THERAPEUTICS INC | $0 | – | -1,250,000 | -100.0% | -0.14% | – |
| Exit | TRITIUM DCFC LIMITEDordinary shares | $0 | – | -400,000 | -100.0% | -0.16% | – | |
| EQ | Exit | EQUILLIUM INC | $0 | – | -600,000 | -100.0% | -0.16% | – |
| Exit | INSPIRATO INCORPORATED | $0 | – | -612,345 | -100.0% | -0.18% | – | |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -200,000 | -100.0% | -0.26% | – |
| ADMA | Exit | ADMA BIOLOGICS INC | $0 | – | -992,840 | -100.0% | -0.30% | – |
| VNDA | Exit | VANDA PHARMACEUTICALS INC | $0 | – | -256,696 | -100.0% | -0.31% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -50,000 | -100.0% | -0.32% | – |
| CLNN | Exit | CLENE INC | $0 | – | -1,100,000 | -100.0% | -0.38% | – |
| ANIP | Exit | ANI PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.39% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -500,000 | -100.0% | -0.41% | – |
| SWTX | Exit | SPRINGWORKS THERAPEUTICS INC | $0 | – | -120,000 | -100.0% | -0.42% | – |
| FBIO | Exit | FORTRESS BIOTECH INC | $0 | – | -4,194,483 | -100.0% | -0.44% | – |
| BBIO | Exit | BRIDGEBIO PHARMA INC | $0 | – | -585,424 | -100.0% | -0.71% | – |
| RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -287,500 | -100.0% | -0.95% | – |
| DAWN | Exit | DAY ONE BIOPHARMACEUTICALS I | $0 | – | -400,000 | -100.0% | -0.98% | – |
| VERU | Exit | VERU INC | $0 | – | -1,100,000 | -100.0% | -1.55% | – |
| TWTR | Exit | TWITTER INC | $0 | – | -300,000 | -100.0% | -1.61% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -1,265,900 | -100.0% | -2.48% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -280,000 | -100.0% | -5.19% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HERON THERAPEUTICS INC | 37 | Q3 2023 | 55.0% |
| LA JOLLA PHARMACEUTICAL CO | 34 | Q2 2022 | 37.1% |
| ROCKET PHARMACEUTICALS INC | 20 | Q3 2023 | 31.6% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q3 2017 | 12.1% |
| ODONATE THERAPEUTICS INC | 17 | Q4 2021 | 69.8% |
| ANAPTYSBIO INC | 16 | Q3 2023 | 18.4% |
| COHERUS BIOSCIENCES INC | 15 | Q3 2023 | 2.7% |
| EQUILLIUM INC | 13 | Q3 2023 | 1.2% |
| RELMADA THERAPEUTICS INC | 12 | Q4 2022 | 6.2% |
| MIRATI THERAPEUTICS INC | 11 | Q3 2023 | 10.9% |
View TANG CAPITAL MANAGEMENT LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-14 |
| 4 | 2024-02-02 |
| 4 | 2023-12-18 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-13 |
| 13F-HR | 2023-08-14 |
| 3 | 2023-06-01 |
| 4 | 2023-06-01 |
| 4 | 2023-05-30 |
View TANG CAPITAL MANAGEMENT LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.